ROYAL BANK OF CANADA - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 49 filers reported holding AYTU BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q4 2022$0511
+6.7%
0.00%
Q3 2022$0479
+0.6%
0.00%
Q2 2022$0
-100.0%
4760.0%0.00%
Q1 2022$1,0000.0%476
-6.3%
0.00%
Q4 2021$1,0000.0%508
-13.0%
0.00%
Q3 2021$1,000
-96.6%
584
-89.9%
0.00%
Q2 2021$29,000
+93.3%
5,764
+189.6%
0.00%
Q1 2021$15,000
+1400.0%
1,990
+1050.3%
0.00%
Q4 2020$1,0001730.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,398,776$8,365,0006.40%
ARMISTICE CAPITAL, LLC 1,333,334$7,973,0000.27%
PIPER SANDLER & CO. 49,590$297,0000.21%
SEARLE & CO. 14,000$84,0000.04%
WINTON GROUP Ltd 28,653$171,0000.01%
Squarepoint Ops LLC 34,862$208,0000.00%
BELLEVUE ASSET MANAGEMENT, LLC 260$2,0000.00%
Clearstead Advisors, LLC 1,421$8,0000.00%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 889$5,0000.00%
Ameritas Investment Partners, Inc. 202$1,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders